高效液相色谱-串联质谱法在他克莫司临床血药浓度监测中的应用

LC-MS/MS Method Monitoring Tacrolimus in Human Whole Blood for Therapeutic Drug Monitoring

  • 摘要: 建立高效液相色谱-质谱联用法监测人全血中他克莫司浓度。选用Shim-pack VP-ODS色谱柱,以甲醇10 mmol•L-1乙酸铵为流动相,采用梯度洗脱进行分离,样品用乙腈进行蛋白沉淀后进样,用3200Qtrap型质谱仪的多重反应监测(MRM)扫描方式进行检测。他克莫司的线性范围为0.5~50.0 μg•L-1,定量下限和最低检测限分别为0.5、0.1 μg•L-1。准确度与精密度结果显示方法日间、日内变异均小于6.8%,相对偏差为-2.99%~2.23%,方法提取回收率均接近100.0%,稳定性较好。该方法快速、灵敏、专属性强、重现性高,适用于他克莫司治疗药物监测(TDM)工作。

     

    Abstract: LC-MS/MS method monitoring tacrolimus (FK506) in human whole blood for therapeutic drug monitoring(TDM) was developed. FK506 and the internal standard were extracted from whole blood by acetonitrile which used as deproteinated solvent, and separated on a Shim-pack VP-ODS column using methanol and 10 mmol•L-1ammonium acetate as mobile phase by gradient elution. Detection was carried out by multiple reaction monitoring on a 3200QTRAP LC-MS/MS system. The assay is linear over the range 0.5-50.0 μg•L-1with a limit of quantity of 0.5 μg•L-1 and a limit of detection of 0.1 μg•L-1. Intra-day and inter-day precision are less than 6.8%, respectively. The relative deviation is in the range of -2.99% to 2.23%. The recoveries of FK506 are nearly 100.0%, and stabilities are good. The method is a rapid, sensitive, selective and reliable method for the determination of monitoring FK506 for TDM.

     

/

返回文章
返回